Literature DB >> 9795275

Comparative investigation of sphingoid bases and fatty acids in ceramides and sphingomyelins from human ovarian malignant tumors and normal ovary.

S N Rylova1, O G Somova, E V Dyatlovitskaya.   

Abstract

Fatty acid and sphingoid base compositions of ceramides and sphingomyelins were investigated in malignant tumors and normal tissue of human ovaries. It has been established that fatty acid compositions of ceramide and sphingomyelin isolated from one tissue are significantly different: the predominant acids are oleic (18:1) in ceramide and palmitic (16:0) in sphingomyelin, which contains much more other saturated acids. These differences are characteristic of both normal and tumor tissues. Sphingoid base compositions of ceramide and sphingomyelin in normal tissue are identical: the major component is sphingenine (over 96%), while ceramides from tumors contain, in addition to sphingenine, a significant amount of sphinganine. In sphingomyelins from tumors, sphinganine content is significantly lower than in ceramides and depends on the type of tumor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795275

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  9 in total

1.  Aneuploid Cell Survival Relies upon Sphingolipid Homeostasis.

Authors:  Yun-Chi Tang; Hui Yuwen; Kaiying Wang; Peter M Bruno; Kevin Bullock; Amy Deik; Stefano Santaguida; Marianna Trakala; Sarah J Pfau; Na Zhong; Tao Huang; Lan Wang; Clary B Clish; Michael T Hemann; Angelika Amon
Journal:  Cancer Res       Date:  2017-08-03       Impact factor: 12.701

2.  Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.

Authors:  Archana Mukhopadhyay; Kayann Tabanor; Rathnam Chaguturu; Jane V Aldrich
Journal:  Cancer Biol Ther       Date:  2013-08-05       Impact factor: 4.742

3.  FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer.

Authors:  Kelly M Kreitzburg; Samuel C Fehling; Charles N Landen; Tracy L Gamblin; Rebecca B Vance; Rebecca C Arend; Ashwini A Katre; Patsy G Oliver; Robert C A M van Waardenburg; Ronald D Alvarez; Karina J Yoon
Journal:  Cancer Lett       Date:  2018-08-16       Impact factor: 8.679

Review 4.  The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.

Authors:  Eric L Smith; Edward H Schuchman
Journal:  FASEB J       Date:  2008-06-20       Impact factor: 5.191

5.  Implication of ceramide, ceramide 1-phosphate and sphingosine 1-phosphate in tumorigenesis.

Authors:  Patricia Gangoiti; Maria H Granado; Alicia Alonso; Félix M Goñi; Antonio Gómez-Muñoz
Journal:  Transl Oncogenomics       Date:  2008-04-10

6.  Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal.

Authors:  Dawei Yang; Xiaofang Yang; Yang Li; Peige Zhao; Rao Fu; Tianying Ren; Ping Hu; Yaping Wu; Hongjun Yang; Na Guo
Journal:  J Transl Med       Date:  2020-06-17       Impact factor: 5.531

7.  Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway.

Authors:  Dorothee Gramatzki; Caroline Herrmann; Caroline Happold; Katrin Anne Becker; Erich Gulbins; Michael Weller; Ghazaleh Tabatabai
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

Review 8.  Using ASMase knockout mice to model human diseases.

Authors:  Guoqiang Hua; Richard Kolesnick
Journal:  Handb Exp Pharmacol       Date:  2013

9.  Expression Patterns and Prognostic Values of ORMDL1 in Different Cancers.

Authors:  Tengjiao Zhu; Yingtong Chen; Shuyuan Min; Fang Li; Yun Tian
Journal:  Biomed Res Int       Date:  2020-10-21       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.